
Looking beyond synthetic chemistry to unlock powerful, naturally derived medicines Each year, World Breast Cancer Awareness Month serves as a …

MSD has made it known that its cancer immunotherapy Keytruda (pembrolizumab) failed to meet its primary endpoint in a Phase …

Researchers at the University of Virginia claim they have discovered a new target for triple-negative breast cancer, a notoriously aggressive …
Jager-van Dijk is new Arletta Pharma Solutions CEOย
Tridem begins phase Ib trial of Parkinsonโs disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns

